Latest news from the FDA – weight loss pill Qnexa has been rejected by a panel with a vote of 10-6, specifying the drug poses some safety risks if taken long term. Get more details of this story plus see photos and a related video below.
Since the news of the FDA weight loss pill rejection became known late last week, it certainly is a wake up call to other diet pill companies, namely Arena Pharmaceuticals and Orexigen Therapeutics Inc, who are due to have their own diet pills evaluated by the Food and Drug Administration in the next several months.
So what exactly did the panel find? Although they all agreed that yes, patients did lose weight, the fact of the matter is that the side effects offset that. Some unsettling effects include “memory lapses, suicidal thoughts, heart palpitations and birth defects”. Kenneth Burman, panel chair, had this to say:
“Some of these side effects are serious and could be life-threatening and must be weighed against a relatively modest weight loss.”
Seriously! I mean, would you really consider taking this diet pill if you were told that some potential side effects included suicidal thoughts? Um, that would be a no brainer for me. Besides, we all know that in order to lose weight you need to watch what you eat and exercise. Plain and simple. Enough said.
Of course, Vivus, Inc., the company who put out Qnexa, is disappointed with the FDA’s ruling, and unfortunately saw their stock plummet over 50% Friday.
What happens now? Reportedly a decision will be made by the FDA on October 28th if they will approve the drug or not. Looks like Vivus has been told that approval could be granted if they conduct another study group of patients – 10,000 of them. According to Reuters, that would be to the tune of $150 million. Yikes!
I’d like to know your thoughts on the FDA weight loss pill rejection. Do you agree that this should not be approved? Check out a related video below.